Comparison of permitted daily exposure (PDE) values for active pharmaceutical ingredients (APIs) - Evidence of a robust approach.

MLA

Sehner, Claudia, et al. “Comparison of Permitted Daily Exposure (PDE) Values for Active Pharmaceutical Ingredients (APIs) - Evidence of a Robust Approach.” Regulatory Toxicology and Pharmacology : RTP, vol. 150, June 2024, p. 105649. EBSCOhost, https://doi.org/10.1016/j.yrtph.2024.105649.

APA

Sehner, C., Bernier, T., Blum, K., Clemann, N., Glogovac, M., Hawkins, W. A., Kohan, M., Linker, F., Lovsin-Barle, E., Osadolor, O., Pfister, T., Schulze, E., Schwind, M., Tuschl, G., & Wiesner, L. (2024). Comparison of permitted daily exposure (PDE) values for active pharmaceutical ingredients (APIs) - Evidence of a robust approach. Regulatory Toxicology and Pharmacology : RTP, 150, 105649. https://doi.org/10.1016/j.yrtph.2024.105649

Chicago

Sehner, Claudia, Tanja Bernier, Kamila Blum, Nicole Clemann, Milica Glogovac, William A Hawkins, Martin Kohan, et al. 2024. “Comparison of Permitted Daily Exposure (PDE) Values for Active Pharmaceutical Ingredients (APIs) - Evidence of a Robust Approach.” Regulatory Toxicology and Pharmacology : RTP 150 (June): 105649. doi:10.1016/j.yrtph.2024.105649.